Clinical Trials
3 trialsNCT05389423 2026-06-01
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT07614282 2026-05-29
Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Columbia University
Phase 1 Not yet recruiting
NCT00001379 2025-06-19
Treatment and Natural History Study of Lymphomatoid Granulomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed